There is no standard answer for how long a 65-year-old AML patient can live, and 65-year-old AML patients need to be treated aggressively. 1. The average survival period of 65-year-old AML patients without treatment is 3~6 months. 2. 65-year-old AML patients who take standardized treatment in time to control the progression of the disease can have their survival period improved, with some patients surviving for 3~5 years and others for more than ten years or for a long period of time. Therapeutic drugs include Vinaclat, Azacitidine, and Cytarabine. Survival time for acute myeloid leukemia at age 65 is associated with risk stratification. Therefore, after discovering the disease, 65-year-old acute myeloid leukemia patients should go to regular hospitals in time and cooperate with doctors to receive regular treatment.